Mixed connective tissue disease--goodbye to all that

Area of Science:

• Rheumatology
• Immunology
• Internal Medicine

Background:

• Mixed Connective Tissue Disease (MCTD) has been historically debated regarding its distinct disease entity status.
• The original characterization of MCTD as a mild disorder with limited organ involvement and low corticosteroid requirements is no longer considered accurate.
• Clinical and serological features of MCTD have evolved, prompting re-evaluation of its classification.

Purpose of the Study:

• To present a historical analysis of the clinical and serological features of Mixed Connective Tissue Disease (MCTD).
• To critically evaluate the concept of MCTD as a distinct disease entity.
• To propose an alternative classification for patients with overlapping autoimmune rheumatic/connective tissue features.

Main Methods:

• Historical review of clinical presentations of MCTD.
• Analysis of serological markers associated with MCTD.
• Longitudinal observation of patient outcomes and disease progression.

Main Results:

• The original description of MCTD as a mild condition is outdated.
• Many patients initially diagnosed with MCTD eventually develop features of defined connective tissue diseases like scleroderma or lupus.
• A significant subset of patients remain undifferentiated, exhibiting overlapping autoimmune features.

Conclusions:

• The concept of MCTD as a separate disease entity is challenged by current evidence.
• An alternative term, 'undifferentiated autoimmune rheumatic/connective tissue disorder', may better represent the clinical spectrum.
• This reclassification acknowledges the dynamic nature of these autoimmune conditions and their potential evolution over time.